Sowell Financial Services LLC Sarepta Therapeutics, Inc. Transaction History

Sowell Financial Services LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$69.38 - $86.75 $60,291 - $75,385	-869 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$72.25 - $168.95 $12,210 - $28,552	169 Added 24.14%	869 $65,000
Q4 2020 Jan 13, 2021	BUY	$125.56 - $178.74 $502 - $714	4 Added 0.57%	700 $119,000
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $44,619 - $60,491	-351 Reduced 33.52%	696 $98,000
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $54,591 - $100,787	587 Added 127.61%	1,047 $168,000
Q1 2020 May 12, 2020	SELL	$82.38 - $131.64 $86,828 - $138,748	-1,054 Reduced 69.62%	460 $45,000
Q4 2019 Feb 07, 2020	BUY	$76.53 - $135.58 $100,560 - $178,152	1,314 Added 657.0%	1,514 $195,000
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $14,562 - $31,382	200 New	200 $15,000
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $316,301 - $677,619	-4,409 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$54.02 - $82.27 $238,174 - $362,728	4,409 New	4,409 $346,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.